Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01029665 · ClinicalTrials.gov registry record
Early Childhood Follow-up of Congenital Diaphragmatic Hernia Survivors
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 16
- Enrollment target
NCT01029665: Completed study, sponsored by Duke University.
NCT01029665 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 16 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01029665 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 16 participants
- Enrollment target
Study Summary
The primary objective of this study is to determine the medical and neurodevelopmental outcomes of congenital diaphragmatic hernia (CDH) survivors at school-age (4-6 years) follow-up. It is generally assumed that older CDH survivors have normal daily function and are able to live normal lives, but this has not been adequately studied.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2008-09 |
| Est. Completion | 2010-12 |
What the finished NCT01029665 record still lists
NCT01029665 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 16 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01029665 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01029665 about?
NCT01029665 is a clinical study titled "Early Childhood Follow-up of Congenital Diaphragmatic Hernia Survivors". The primary objective of this study is to determine the medical and neurodevelopmental outcomes of congenital diaphragmatic hernia (CDH) survivors at school-age (4-6 years) follow-up. It is generally assumed that older CDH survivors have normal daily function and are able to live normal lives, but t...
What is the current status of trial NCT01029665?
This trial is currently completed. The enrollment target is 16 participants. The study started on 2008-09. Estimated completion is 2010-12.
Who is sponsoring clinical trial NCT01029665?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia